Adam Levy - Feb 13, 2024 Form 4 Insider Report for Mineralys Therapeutics, Inc. (MLYS)

Role
CFO and Secretary
Signature
/s/ Adam Levy
Stock symbol
MLYS
Transactions as of
Feb 13, 2024
Transactions value $
$0
Form type
4
Date filed
2/15/2024, 04:26 PM
Previous filing
Mar 21, 2023
Next filing
Jun 13, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MLYS Stock Option Award $0 +200K $0.00 200K Feb 13, 2024 Common Stock 200K $14.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 25% of the total number of shares of Common Stock subject to the option on the first anniversary of the grant date, and as to 1/48th of the total number of shares of Common Stock subject to the option on each monthly anniversary thereafter.